Se We Bo Chi
FDA investigator
Appears on 1 document from 2017, mostly at sites in Japan. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 8.0
- Observations per 483
- 2017
- First seen
- 2017
- Most recent
What they cite most
From 8 observations- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.67Equipment cleaning and maintenance2
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.56Sanitation1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
Activity by year
2017: 1
Where
Japan 1
Often inspects with
Is Se We Bo Chi coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2017-09-27 | 483 Chugai Pharma Manufacturing Co., LtdSep 27, 2017 · TKY, Japan | TKY, Japan | 8 |
About this profile
What does Se We Bo Chi inspect?
Se We Bo Chi appears on 1 document on file covering 1 site, mostly in Japan.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.67 and 21 CFR 211.84.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Se We Bo Chi is dated Sep 27, 2017.